Cationic Antimicrobial Peptides and Biogenic Silver Nanoparticles Kill Mycobacteria without Eliciting DNA Damage and Cytotoxicity in Mouse Macrophages

ABSTRACT With the emergence of multidrug-resistant mycobacterial strains, better therapeutic strategies are required for the successful treatment of the infection. Although antimicrobial peptides (AMPs) and silver nanoparticles (AgNPs) are becoming one of the popular antibacterial agents, their antimycobacterial potential is not fully evaluated. In this study, we synthesized biogenic-silver nanoparticles using bacterial, fungal, and plant biomasses and analyzed their antibacterial activities in combination with AMPs against mycobacteria. Mycobacterium smegmatis was found to be more susceptible to AgNPs compared to M. marinum. We found that NK-2 showed enhanced killing effect with NP-1 and NP-2 biogenic nanoparticles at a 0.5-ppm concentration, whereas LLKKK-18 showed antibacterial activity only with NP-2 at 0.5-ppm dose against M. smegmatis. In case of M. marinum NK-2 did not show any additive activity with NP-1 and NP-2 and LLKKK-18 alone completely inhibited the bacterial growth. Both NP-1 and NP-2 also showed increased killing of M. smegmatis in combination with the antituberculosis drug rifampin. The sizes and shapes of the AgNPs were determined by transmission electron microscopy and dynamic light scattering. AgNPs showed no cytotoxic or DNA damage effects on macrophages at the mycobactericidal dose, whereas treatment with higher doses of AgNPs caused toxicity and micronuclei formation in cytokinesis blocked cells. Macrophages actively endocytosed fluorescein isothiocyanate-labeled AgNPs resulting in nitric oxide independent intracellular killing of M. smegmatis. Apoptosis and cell cycle studies showed that treatment with higher dose of AgNPs arrested macrophages at the G1-phase. In summary, our data suggest the combined effect of biogenic-AgNPs and antimicrobial peptides as a promising antimycobacterial template.

[1]  C. Bleck,et al.  On the killing of mycobacteria by macrophages , 2007, Cellular microbiology.

[2]  Nelson Durán,et al.  Silver nanoparticles: a brief review of cytotoxicity and genotoxicity of chemically and biogenically synthesized nanoparticles , 2012, Journal of applied toxicology : JAT.

[3]  Ruchi Yadav,et al.  Biogenic synthesis of silver nanoparticles and their synergistic effect with antibiotics: a study against gram-positive and gram-negative bacteria. , 2010, Nanomedicine : nanotechnology, biology, and medicine.

[4]  Kirsten Sandvig,et al.  Endocytosis and intracellular transport of nanoparticles: Present knowledge and need for future studies , 2011 .

[5]  M. Fenech.  Cytokinesis-block micronucleus cytome assay , 2007, Nature Protocols.

[6]  R. Albrecht,et al.  Toxicity assessments of multisized gold and silver nanoparticles in zebrafish embryos. , 2009, Small.

[7]  J. Bayona,et al.  Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis , 2010, The Lancet.

[8]  K. Paknikar,et al.  Cellular responses induced by silver nanoparticles: In vitro studies. , 2008, Toxicology letters.

[9]  V. Sharma,et al.  Silver nanoparticles: green synthesis and their antimicrobial activities. , 2009, Advances in colloid and interface science.

[10]  F. Cui,et al.  A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. , 2000, Journal of biomedical materials research.

[11]  H. Kim,et al.  Size-dependent cellular toxicity of silver nanoparticles. , 2012, Journal of biomedical materials research. Part A.

[12]  V. Vincent,et al.  Mycobacterial infections in domestic and wild animals due to Mycobacterium marinum, M. fortuitum, M. chelonae, M. porcinum, M. farcinogenes, M. smegmatis, M. scrofulaceum, M. xenopi, M. kansasii, M. simiae and M. genavense. , 2001, Revue scientifique et technique.

[13]  J. Jang,et al.  Antibacterial properties of novel poly(methyl methacrylate) nanofiber containing silver nanoparticles. , 2008, Langmuir : the ACS journal of surfaces and colloids.

[14]  Arezou A Ghazani,et al.  Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. , 2006, Nano letters.

[15]  Dakrong Pissuwan,et al.  Functionalised gold nanoparticles for controlling pathogenic bacteria. , 2010, Trends in biotechnology.

[16]  R. Müller,et al.  Influence of polysaccharide coating on the interactions of nanoparticles with biological systems. , 2006, Biomaterials.

[17]  H. Nikaido,et al.  Mycobacterial cell wall: structure and role in natural resistance to antibiotics. , 1994, FEMS microbiology letters.

[18]  C. Thompson,et al.  Role of the Mycobacterium tuberculosis P55 Efflux Pump in Intrinsic Drug Resistance, Oxidative Stress Responses, and Growth , 2009, Antimicrobial Agents and Chemotherapy.

[19]  Zhi-yuan Li,et al.  Preparation and study of polyacryamide-stabilized silver nanoparticles through a one-pot process. , 2006, The journal of physical chemistry. B.

[20]  A. Barton,et al.  Mycobacterium marinum infection causing septic arthritis and osteomyelitis. , 1997, British journal of rheumatology.

[21]  P. Kuo,et al.  Formation of silver nanoparticles under structured amino groups in pseudo-dendritic poly(allylamine) derivatives , 2003 .

[22]  A. Khan,et al.  Evaluation of antibacterial activity of silver nanoparticles against MSSA and MRSA on isolates from skin infections , 2011 .

[23]  Sonal Thakore,et al.  Morphology and antibacterial activity of carbohydrate-stabilized silver nanoparticles. , 2010, Carbohydrate research.

[24]  Yan Lu,et al.  In Situ Formation of Ag Nanoparticles in Spherical Polyacrylic Acid Brushes by UV Irradiation , 2007 .

[25]  H. Autrup,et al.  Cytotoxicity and genotoxicity of silver nanoparticles in the human lung cancer cell line, A549 , 2011, Archives of Toxicology.

[26]  M. Leippe,et al.  Candidacidal activity of shortened synthetic analogs of amoebapores and NK-lysin , 1999, Medical Microbiology and Immunology.

[27]  Biju Jacob,et al.  Toxicity and antibacterial assessment of chitosancoated silver nanoparticles on human pathogens and macrophage cells , 2012, International journal of nanomedicine.

[28]  H. Gendelman,et al.  Macrophage endocytic trafficking of antiretroviral nanoparticles. , 2011, Nanomedicine.

[29]  Biju Jacob,et al.  An investigation on the antibacterial, cytotoxic, and antibiofilm efficacy of starch-stabilized silver nanoparticles. , 2012, Nanomedicine : nanotechnology, biology, and medicine.

[30]  M. Leippe,et al.  Membrane-active antimicrobial peptides and human placental lysosomal extracts are highly active against mycobacteria , 2011, Peptides.

[31]  Stephanie E. A. Gratton,et al.  The effect of particle design on cellular internalization pathways , 2008, Proceedings of the National Academy of Sciences.

[32]  Dae Hong Jeong,et al.  Antimicrobial effects of silver nanoparticles. , 2007, Nanomedicine : nanotechnology, biology, and medicine.

[33]  Michael T. Wilson,et al.  Lethal photosensitisation of Staphylococcus aureus using a toluidine blue O-tiopronin-gold nanoparticle conjugate , 2007 .

[34]  V. Vincent,et al.  Mycobacterial infections in domestic and wild animals due to Mycobacterium marinum, Mycobacterium fortuitum, Mycobacterium chelonae, Mycobacterium porcinum, Mycobacterium farcinogenes, Mycobacterium smegmatis, Mycobacterium scrofulaceum, Mycobacterium xenopi, Mycobacterium kansasii, Mycobacterium si , 2001 .

[35]  Milan Kolar,et al.  Silver colloid nanoparticles: synthesis, characterization, and their antibacterial activity. , 2006, The journal of physical chemistry. B.

[36]  S. Murugan,et al.  The green synthesis, characterization and evaluation of the biological activities of silver nanoparticles synthesized from Iresine herbstii leaf aqueous extracts. , 2012, Colloids and surfaces. B, Biointerfaces.

[37]  B. Mishra,et al.  Cathelicidin is involved in the intracellular killing of mycobacteria in macrophages , 2011, Cellular microbiology.

[38]  H. Kress,et al.  Dynamic life and death interactions between Mycobacterium smegmatis and J774 macrophages , 2006, Cellular microbiology.

[39]  Linxi Wu,et al.  Scavenger receptor mediated endocytosis of silver nanoparticles into J774A.1 macrophages is heterogeneous. , 2012, ACS nano.

[40]  Wagner Fontes,et al.  Plant defense and antimicrobial peptides. , 2005, Protein and peptide letters.

[41]  M. Leippe,et al.  The Antimicrobial Peptide NK-2, the Core Region of Mammalian NK-Lysin, Kills Intraerythrocytic Plasmodium falciparum , 2008, Antimicrobial Agents and Chemotherapy.

[42]  K. Matsuzaki.  Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes. , 1999, Biochimica et biophysica acta.

[43]  C. Patil,et al.  Studies on Silver Accumulation and Nanoparticle Synthesis By Cochliobolus lunatus , 2011, Applied biochemistry and biotechnology.

[44]  J. Palomino,et al.  Efflux as a mechanism for drug resistance in Mycobacterium tuberculosis. , 2011, FEMS immunology and medical microbiology.

[45]  R. Hurt,et al.  Controlled release of biologically active silver from nanosilver surfaces. , 2010, ACS nano.

[46]  M. Leippe,et al.  NK-Lysin and Its Shortened Analog NK-2 Exhibit Potent Activities against Trypanosoma cruzi , 2003, Antimicrobial Agents and Chemotherapy.

[47]  James M. Wilson,et al.  Cathelicidins - a family of multifunctional antimicrobial peptides , 2003, Cellular and Molecular Life Sciences CMLS.

[48]  D. Eastwood,et al.  Mycobacterium kansasii causing septic arthritis and osteomyelitis in a child. , 2010, The Pediatric infectious disease journal.

[49]  Brahim Lounis,et al.  Cathepsin L digestion of nanobioconjugates upon endocytosis. , 2009, ACS nano.

[50]  M. Hande,et al.  Cytotoxicity and genotoxicity of silver nanoparticles in human cells. , 2009, ACS nano.

[51]  R. L. Jones,et al.  Unique cellular interaction of silver nanoparticles: size-dependent generation of reactive oxygen species. , 2008, The journal of physical chemistry. B.

[52]  H. Drugeon,et al.  Comparison of the in vitro activities of rifapentine and rifampicin against Mycobacterium tuberculosis complex. , 2000, The Journal of antimicrobial chemotherapy.

[53]  H. Sue,et al.  Antimicrobial efficacy of zinc oxide quantum dots against Listeria monocytogenes, Salmonella Enteritidis, and Escherichia coli O157:H7. , 2009, Journal of food science.

[54]  Hao Li,et al.  Antibacterial activities of zinc oxide nanoparticles against Escherichia coli O157:H7 , 2009, Journal of applied microbiology.

[55]  Murugesan V. S. Rajaram,et al.  Structural Differences in Lipomannans from Pathogenic and Nonpathogenic Mycobacteria That Impact CD1b-restricted T Cell Responses* , 2011, The Journal of Biological Chemistry.

[56]  Ying Liu,et al.  Surface chemistry and aspect ratio mediated cellular uptake of Au nanorods. , 2010, Biomaterials.